Literature DB >> 12421892

Two patients with unusual forms of varicella-zoster virus vasculopathy.

Donald H Gilden1, Howard L Lipton, James S Wolf, William Akenbrandt, John E Smith, Ravi Mahalingam, Bagher Forghani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12421892     DOI： 10.1056/NEJMoa020841

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

1.  A virulent vasculopathy.

Authors:  A Molloy; D Forde; C De Gascun; N Fanning; G Wyse; O O'Toole
Journal:  BMJ Case Rep       Date:  2011-03-25

Review 2.  Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature.

Authors:  Aaron Haug; Ravi Mahalingam; Randall J Cohrs; D Scott Schmid; John R Corboy; Don Gilden
Journal:  J Neurol Sci       Date:  2010-02-19       Impact factor: 3.181

3.  Association of varicella zoster virus with giant cell arteritis.

Authors:  Don Gilden
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-06-03

4.  Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement.

Authors:  Richard Salazar; Andrew N Russman; Maria A Nagel; Randall J Cohrs; Ravi Mahalingam; D Scott Schmid; Bette K Kleinschmidt-DeMasters; Eve M VanEgmond; Don Gilden
Journal:  Arch Neurol       Date:  2011-04

5.  Varicella zoster virus vasculopathy: a treatable form of rapidly progressive multi-infarct dementia after 2 years' duration.

Authors:  Brian Silver; Maria A Nagel; Ravi Mahalingam; Randall Cohrs; D Scott Schmid; Don Gilden
Journal:  J Neurol Sci       Date:  2012-08-27       Impact factor: 3.181

6.  Varicella-zoster virus at relapses of multiple sclerosis.

Authors:  Julio Sotelo; Graciela Ordoñez; Benjamin Pineda
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

7.  Successful antiviral treatment after 6years of chronic progressive neurological disease attributed to VZV brain infection.

Authors:  Don Gilden; Charles Grose; Teresa White; Lidia Nagae; Robert L Hendricks; Randall J Cohrs; Maria A Nagel
Journal:  J Neurol Sci       Date:  2016-07-15       Impact factor: 3.181

Review 8.  Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Lancet Neurol       Date:  2009-08       Impact factor: 44.182

9.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

Review 10.  The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

Authors:  M A Nagel; R J Cohrs; R Mahalingam; M C Wellish; B Forghani; A Schiller; J E Safdieh; E Kamenkovich; L W Ostrow; M Levy; B Greenberg; A N Russman; I Katzan; C J Gardner; M Häusler; R Nau; T Saraya; H Wada; H Goto; M de Martino; M Ueno; W D Brown; C Terborg; D H Gilden
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.